Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : OCX save search
Oncocyte Announces Executive Leadership Changes
Published: 2022-11-30 (Crawled : 00:00) - globenewswire.com
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: -0.02%
H: 3.77%
C: 1.11%
Oncocyte Announces the Appointment of Louis E. Silverman as a Member of Its Board of Directors
Published: 2022-11-30 (Crawled : 00:00) - globenewswire.com
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: -0.02%
H: 3.77%
C: 1.11%
Movers & Shakers: IPI, Lucy Therapeutics, Valneva and More Add New Leaders
Published: 2022-11-18 (Crawled : 14:00) - biospace.com/
CDMO M | $6.27 -3.83% 350K
|
Health Technology
|
| O: 4.17%
H: 0.88%
C: -2.85%
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 0.0%
H: 3.24%
C: 3.24%
valneva
Avid Bioservices Appoints Oksana Lukash as Vice President, People
Published: 2022-11-16 (Crawled : 13:20) - globenewswire.com
CDMO M | $6.27 -3.83% 350K
|
Health Technology
|
| O: -0.96%
H: 0.94%
C: -5.68%
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 2.99%
H: 4.02%
C: -7.96%
Oncocyte Reports Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 5.02%
H: 1.56%
C: -4.73%
financial results
Oncocyte to Announce Third Quarter 2022 Financial Results
Published: 2022-10-27 (Crawled : 22:00) - biospace.com/
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: -1.31%
H: 2.58%
C: -12.35%
financial results
DetermaIO™ Clinical Test to be used in SWOG Cancer Research Network Biomarker Study for Breast Cancer
Published: 2022-10-06 (Crawled : 20:00) - biospace.com/
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 0.03%
H: 9.14%
C: 4.24%
research test breast biomarker cancer study
Oncocyte to Participate at the Lake Street 6th Annual Best Ideas Growth Conference
Published: 2022-08-31 (Crawled : 22:00) - biospace.com/
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 1.78%
H: 4.23%
C: -4.14%
conference growth
Oncocyte Announces Publication of the Validation of DetermaIO in Predicting Immune Therapy Response in Metastatic Bladder Cancer
Published: 2022-08-24 (Crawled : 12:20) - globenewswire.com
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: -1.09%
H: 3.44%
C: 1.94%
response bladder therapy cancer publication
Oncocyte Reports Second Quarter 2022 Financial Results
Published: 2022-08-10 (Crawled : 23:00) - biospace.com/
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 1.16%
H: 10.34%
C: 9.3%
results
Oncocyte Announces the Appointment of John Peter Gutfreund as Independent Member of Its Board of Directors Effective July 28, 2022
Published: 2022-08-01 (Crawled : 10:00) - biospace.com/
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 1.29%
H: 0.31%
C: -2.63%
Oncocyte Announces Market Entry and Early Adopter Program for Transplant Rejection Monitoring Business
Published: 2022-07-13 (Crawled : 13:00) - biospace.com/
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: -0.05%
H: 5.81%
C: 5.8%
program market
Oncocyte Presents DetermaIO™ Data in Podium Presentation at ESMO World Congress on Gastrointestinal Cancer 2022
Published: 2022-07-06 (Crawled : 13:00) - biospace.com/
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: -1.01%
H: 2.64%
C: 1.15%
gastrointestinal presentation cancer
Oncocyte Reports First Quarter 2022 Financial Results
Published: 2022-05-11 (Crawled : 21:00) - biospace.com/
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: -2.59%
H: 2.65%
C: 0.0%
results
Oncocyte Completes Validation of TheraSure™ Transplant Monitor Test Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
Published: 2022-05-05 (Crawled : 20:00) - biospace.com/
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: -1.65%
H: 5.88%
C: 0.0%
treatment test
Oncocyte to Announce First Quarter 2022 Financial Results
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 0.0%
H: 0.88%
C: 0.0%
results
Oncocyte Corporation Announces Pricing of Public Offering of Common Stock and Warrants
Published: 2022-04-14 (Crawled : 03:00) - globenewswire.com
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 0.79%
H: 5.43%
C: -1.56%
offering corporation
Oncocyte Corporation Announces Pricing of Registered Direct Offering of 11,765 Shares of Series A Convertible Preferred Stock
Published: 2022-04-13 (Crawled : 22:00) - globenewswire.com
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 0.79%
H: 5.43%
C: -1.56%
offering corporation
Oncocyte Corporation Announces Proposed Public Offering of Common Stock and Warrants
Published: 2022-04-13 (Crawled : 22:00) - globenewswire.com
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 0.79%
H: 5.43%
C: -1.56%
offering corporation
Zynerba Pharmaceuticals Announces Planned Retirement of Suzanne Hanlon and Appoints Albert P. Parker as Chief Legal Officer
Published: 2022-02-15 (Crawled : 12:00) - zynerba.com
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 0.74%
H: 4.04%
C: 4.04%
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: 0.65%
H: 6.41%
C: 4.49%
als ces
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.